Literature DB >> 7803399

Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments.

P Foran1, C C Shone, J O Dolly.   

Abstract

Botulinum neurotoxin serotype B (BoNT/B) and tetanus toxin (TeTx) block neuroexocytosis through selective endoproteolysis of vesicle-associated membrane protein (VAMP). The enzymological properties of both toxins were compared for the first time in their cleavage of VAMP and various sized fragments using a sensitive chromatographic assay. The optimal substrate sizes for the zinc-dependent protease activities of the light chains of TeTx and BoNT/B were established using synthetic peptides corresponding to the hydrophilic core of VAMP (30-62 amino acids in length). TeTx was found to selectively cleave the largest peptide at a single site, Gln76-Phe77. It exhibited the most demanding specificity, requiring the entire hydrophilic domain (a 62-mer) for notable hydrolysis, whereas BoNT/B efficiently cleaved the much smaller 40-mer. Thus, an unusually long N-terminal sequence of 44 amino acids upstream of the scissile bond is required for the selective hydrolysis of VAMP by TeTx. Using the largest peptide, BoNT/B and TeTx exhibited approximately 50% and 35%, respectively, of the activities shown toward intact VAMP, detergent solubilized from synaptic vesicles. Given the large size of the smallest substrates, it is possible that these neurotoxins recognize and require a three-dimensional structure. Although both toxins were inactivated by divalent metal chelators, neither was antagonized by phosphoramidon or ASQFETS (a substrate-related peptide that spans the cleavage site), and TeTx was only feebly inhibited by captopril; also, they were distinguishable in their relative activities at different pHs, temperatures, and ionic strengths. These collective findings are important in the design of effective inhibitors for both toxins, as well as in raising the possibility that TeTx and BoNT/B interact somewhat differently with VAMP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803399     DOI: 10.1021/bi00255a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  28 in total

1.  A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity.

Authors:  Michael Adler; Harlan F Shafer; Heather A Manley; Brennie E Hackley; James D Nicholson; James E Keller; Michael C Goodnough
Journal:  J Protein Chem       Date:  2003-07

2.  Synaptic vesicle chips to assay botulinum neurotoxins.

Authors:  Géraldine Ferracci; Raymond Miquelis; Shunji Kozaki; Michael Seagar; Christian Lévêque
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

3.  A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.

Authors:  Hong Fang; Wentian Luo; Jim Henkel; Joseph Barbieri; Neil Green
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 4.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

5.  Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.

Authors:  B Hallis; B A James; C C Shone
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

6.  Proteolysis of synthetic peptides by type A botulinum neurotoxin.

Authors:  J J Schmidt; K A Bostian
Journal:  J Protein Chem       Date:  1995-11

7.  Inhibition of catalytic activities of botulinum neurotoxin light chains of serotypes A, B and E by acetate, sulfate and calcium.

Authors:  Rahman M Mizanur; John Gorbet; S Swaminathan; S Ashraf Ahmed
Journal:  Int J Biochem Mol Biol       Date:  2012-09-25

8.  The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Authors:  Rahman M Mizanur; Verna Frasca; Subramanyam Swaminathan; Sina Bavari; Robert Webb; Leonard A Smith; S Ashraf Ahmed
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

9.  Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells.

Authors:  Min Dong; William H Tepp; Eric A Johnson; Edwin R Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

10.  Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F.

Authors:  James J Schmidt; Robert G Stafford
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.